The infant age at follow-up was similar in the GLP1-RA group (neonates aged 0–28 days, 8%; infants aged 28 days to 2 years, 76%; and children aged >2 years, 16%), the diabetes reference group (neonates, 0%; infants, 63%; and children, 37%) and the overweight/obese reference group (neonates, 4%; infants, 87%; and children, 9%). The gene discussed is GCG; the disease is diabetes mellitus.